Clinical Trials Logo

Clinical Trial Summary

Access to effective pediatric mental health treatment is a major public health concern in the United States as paucity of pediatric providers leading to long wait times, financial burden, and stigma pose significant barriers to treatment. Digital mental health promises to remedy many chronic problems faced in providing timely and accessible mental health interventions to children. With that in mind, the investigators and Neuromotion Inc. created Mightier, an app-based heart rate biofeedback videogame platform designed to teach and facilitate practice of emotional regulation skills. The technology behind Mightier is backed by three trials showing clinical efficacy and since commercial launch 75% of families who have engaged with the product report improvement. However, Neuromotion's core mission remains increasing access to care, and the direct-to-consumer distribution of digital health also faces access challenges. The investigators propose that access to effective digital mental health interventions can be increased by meeting families where they already know to seek care: the traditional healthcare system. The investigators have partnered with a nationwide behavioral health insurance provider to pilot the integration of Mightier with traditional healthcare. Families will be recruited via direct outreach, social media, or healthcare provider referral. Participating children will be randomized into Mightier or treatment as usual control groups for 6 months. Behavioral healthcare utilization will be observed for 12 months. Through this work the investigators will demonstrate the value of Mightier to various stakeholders via decreased long-term healthcare utilization, confirm that Mightier use results in decreased symptoms of emotional dysregulation, irritability, and parent stress, and explore relationships among Mightier use, healthcare utilization, and symptoms. Ultimately this work will pave the way forward for large scale integration of digital healthcare and more traditional healthcare avenues while simultaneously increasing Mightier's ability to reach children in need.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04732806
Study type Interventional
Source Neuromotion Labs
Contact Jason Kahn, PhD
Phone 888-978-7495
Email jason@mightier.com
Status Recruiting
Phase N/A
Start date March 10, 2021
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04210648 - Effectiveness and Security Testing of a Mobile App for Self-Managing Emotion Dysregulation N/A
Completed NCT04349709 - Emotional Regulation in Teens: Improvement of Constructive Skills N/A
Completed NCT01730261 - Online Emotional Regulation Group Treatment Phase 1
Terminated NCT04826874 - Affect Labeling - Experimental Evaluation and Behavioral Intervention N/A
Recruiting NCT01299740 - Skills Group for Children With Emotional Dysregulation and Their Parents N/A